$465.67−0.30%Close 13 Nov 2026 · Market value $253.8B
Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.
Valuation
Amgen is valued at $253.8B on its latest close. Its price is 27.0 times its earnings.
| Market value | $253.8B |
|---|
| Enterprise value | $292.7B |
|---|
| Price / earnings | 27.03 |
|---|
| Price / sales | 6.52 |
|---|
| Price / book | 17.68 |
|---|
| EV / EBITDA | 17.12 |
|---|
| EV / sales | 7.52 |
|---|
| Price / free cash flow | 26.49 |
|---|
| Price / free cash flow, own 5-year average | 18.47 |
|---|
| EV / EBIT | 23.36 |
|---|
| EV / free cash flow | 30.75 |
|---|
| Free cash flow yield | 3.8% |
|---|
| Dividend yield | 2.1% |
|---|
Share price
| Latest close | $465.67 |
|---|
| Day's change | −0.3% |
|---|
| 52-week high | $483.99 |
|---|
| 52-week low | $312.39 |
|---|
| From 52-week high | −3.8% |
|---|
| Return · 1 month | +7.7% |
|---|
| Return · 3 months | +7.4% |
|---|
| Return · year to date | +42.3% |
|---|
| Return · 1 year | +38.5% |
|---|
| Beta · 1 year against the S&P 500 | 0.49 |
|---|
| 50-day average | $425.31 |
|---|
| 200-day average | $381.01 |
|---|
| RSI 14 | 61.8 |
|---|
| Average volume · 20 sessions | 2.7M |
|---|
Margins and returns
For fiscal 2025, as filed.
| Gross margin | 67.2% |
|---|
| Operating margin | 24.7% |
|---|
| Net margin | 21.0% |
|---|
| Free cash flow margin | 22.0% |
|---|
| Return on equity | 106% |
|---|
| Return on assets | 8.6% |
|---|
| Return on invested capital | 11.8% |
|---|
| Return on invested capital, 5-year average | 13.7% |
|---|
| Return on capital employed | 13.6% |
|---|
| Stock-based compensation / revenue | 1.3% |
|---|
Financial position
At the end of fiscal 2025.
| Cash and equivalents | $9.13B |
|---|
| Total debt | $55.44B |
|---|
| Net debt | $46.31B |
|---|
| Current ratio | 1.14 |
|---|
| Quick ratio | 1.01 |
|---|
| Debt / equity | 6.40 |
|---|
| Net debt / EBITDA | 3.25 |
|---|
| Interest coverage | 3.30 |
|---|
Growth
| Revenue, latest quarter on a year | +8.5% |
|---|
| Revenue, twelve months on a year | +8.2% |
|---|
| EPS, latest quarter on a year | +19.4% |
|---|
| EPS, twelve months on a year | +33.4% |
|---|
| Revenue, 5-year compound | +7.6% |
|---|
| Revenue, 10-year compound | +5.4% |
|---|
| Net income, 5-year compound | +1.2% |
|---|
| Free cash flow, 5-year compound | −3.9% |
|---|
| EPS, 5-year compound | +2.9% |
|---|
Shares and dividends
For fiscal 2025, as filed.
| Diluted shares | 542M |
|---|
| Shares outstanding, 5-year compound | −1.7% |
|---|
| Net share repurchases | $0.00 |
|---|
| Dividends per share | $9.66 |
|---|
| Dividend payout | 66.5% |
|---|
Taxes
For fiscal 2025, as filed.
| Income tax expense | $1.26B |
|---|
| Effective tax rate | 14.1% |
|---|
AMGN in the terminal
Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.